Toxin-Derived Peptides as Potentials Weapons Against Cancer

Area of Science:

• Biochemistry
• Pharmacology
• Toxicology

Background:

• Cancer is a leading cause of death globally, necessitating novel therapeutic strategies.
• Conventional cancer treatments often lack specificity and cause significant adverse effects.
• Animal toxins represent an underexplored reservoir of bioactive compounds with potential anticancer properties.

Purpose of the Study:

• To review the potential of animal-derived toxin peptides as a source for novel anticancer drug development.
• To explore the discovery, development, and therapeutic applications of these compounds against various cancers.
• To highlight their mechanisms of action and potential for targeted cancer therapy.

Main Methods:

• Literature review of studies on animal toxins and their anticancer activities.
• Analysis of in vitro and in vivo data on the antiproliferative and cytotoxic effects of toxin peptides.
• Examination of toxicity profiles and mechanisms of action of selected compounds.

Main Results:

• Peptides from diverse animal sources (scorpions, snakes, bees, spiders, frogs) exhibit significant antiproliferative and cytotoxic activities against cancer cells.
• Several toxin-derived compounds have shown efficacy in preclinical models for various prevalent cancer types.
• Toxin peptides offer potential for targeted drug delivery and reduced side effects compared to conventional therapies.

Conclusions:

• Animal toxins are a promising source for the development of novel, targeted anticancer agents.
• Further research into toxin peptide mechanisms and preclinical/clinical evaluation is warranted.
• This approach represents a paradigm shift towards more efficient and specific cancer therapies.